| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| CD3-H52P3 | Human | Human CD133 Full Length Protein-VLP (HEK293) |
|
||
| CD3-H82Q8 | Human | Biotinylated Human CD133 Protein, His,Avitag™ |  |
|
|
| CD3-H52H1 | Human | Human CD133 Full Length Protein, His Tag (Nanodisc) |  |
|
|
| CD3-H82E6 | Human | Biotinylated Human CD133 Protein, His,Avitag™ (Nanodisc) |  |
|
|
| CD3-H52H4 | Human | Human CD133 Protein, His Tag |  |
|
|
2e5 of Anti-CD133 CAR-293 cells were stained with 100 μL of 3 μg/mL of Human CD133 Full Length, His Tag (Nanodisc) (Cat. No. CD3-H52H1) and negative control protein respectively, washed and then followed by PE-anti-His Tag antibody and analyzed with FACS (QC tested).
Monoclonal Anti-Human CD133 Antibody, Human IgG1 immobilized on CM5 Chip can bind Biotinylated Human CD133 Protein, His,Avitag (Cat. No. CD3-H82Q8) with an affinity constant of 22.9 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (Routinely tested).
Monoclonal Anti-Human CD133 Antibody, Human IgG1 captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Biotinylated Human CD133, His,Avitag (Nanodisc) (Cat. No. CD3-H82E6) with an affinity constant of 61.2 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| anti-CD133-CAR vector-transduced T cells | Phase 2 Clinical | The General Hospital Of The People'S Liberation Army | Liver Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Breast Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Brain Neoplasms; Colorectal Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
FLAG
Star Staining
ViruStop
Aneuro
ComboX
ActiveMax
GENPower
ClinMax 
